PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database - Gérard, Alexandre O.; Merino, Diane; Benzaquen, Jonathan; Destere, Alexandre; Borchiellini, Delphine; Gosset, Clément; Rocher, Fanny; Andreani, Marine; Marquette, Charles-Hugo; Montaudié, Henri; Drici, Milou-Daniel; Sicard, Antoine (Frontiers in Immunology, 2025)